← Back to directory

Steven M. Larson

Researcher Next ID · RN-023433

Researcher · Medicine

Memorial Sloan Kettering Cancer Center

New York, Pakistan

Not currently recruitingFunding unknown
Works count
1,120
Citation count
60,553
H-index
132
i10-index
552

Research interests

Medicine
Radiopharmaceutical Chemistry and Applications
Medical Imaging Techniques and Applications
Prostate Cancer Treatment and Research
Monoclonal and Polyclonal Antibodies Research
Radiomics and Machine Learning in Medical Imaging

Publications

  • 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

    Thyroid · 2025 · 10.1177/10507256251363120

  • Radioimmunotherapy of human tumours

    Nature reviews. Cancer · 2015 · 10.1038/nrc3925

  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

    Science Translational Medicine · 2014 · 10.1126/scitranslmed.3009524

  • Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1209288

  • Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

    Clinical Cancer Research · 2013 · 10.1158/1078-0432.ccr-13-0231

  • Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

    Journal of Clinical Investigation · 2011 · 10.1172/jci45600

  • Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

    Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.25.9259

  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

    The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)60172-9

  • 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo

    Journal of Nuclear Medicine · 2010 · 10.2967/jnumed.110.076174

  • Fluorescent Silica Nanoparticles with Efficient Urinary Excretion for Nanomedicine

    Nano Letters · 2008 · 10.1021/nl803405h

  • Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

    Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-07-0674

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-07-1506

  • Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

    PubMed · 2006

  • Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

    The Journal of Clinical Endocrinology & Metabolism · 2006 · 10.1210/jc.2005-1534

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Clinical Cancer Research · 2005 · 10.1158/1078-0432.ccr-04-2626

  • Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma

    Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.12.072

  • A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    PubMed · 2003

  • Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

    Nature Medicine · 2003 · 10.1038/nm827

  • Targeted α particle immunotherapy for myeloid leukemia

    Blood · 2002 · 10.1182/blood.v100.4.1233.h81602001233_1233_1239

  • Effect of respiratory gating on quantifying PET images of lung cancer.

    PubMed · 2002

  • Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

    International Journal of Radiation Oncology*Biology*Physics · 2000 · https://doi.org/10.1016/s0360-3016(00)00467-3

  • Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion Glycolysis

    Clinical Positron Imaging · 1999 · 10.1016/s1095-0397(99)00016-3

  • Radioimmunotherapy with alpha-emitting nuclides

    European Journal of Nuclear Medicine and Molecular Imaging · 1998 · 10.1007/s002590050306

  • Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding

    Cancer · 1997 · 10.1002/(sici)1097-0142(19971215)80:12+<2505::aid-cncr24>3.0.co;2-f

  • Prediction of survival in glioma patients by means of positron emission tomography

    Journal of neurosurgery · 1985 · 10.3171/jns.1985.62.6.0816

Current projects

    No projects listed.